Mr. Ahmad Mortazavi serves as Chief Executive Officer & Board Member at e-Therapeutics. He has been appointed Executive Chairman with effect from 11th February 2020. Mr Mortazavi has extensive experience in the biotechnology sector and financial markets. Recent roles include CEO of Silence Therapeutics plc from 2012-2018 as well as a founder shareholder of Evolution Group, a U.K. based Investment Bank, from 2001-2008. Ali is an experienced investor in small companies and has held numerous declarable stakes in listed and private biotechnology and technology companies. Current directorships: Hannesami LLP. Previous directorships held in the last 5 years: Silence therapeutics PLC He served as Co-Chairman at Ultromics.